SEC Form 4 · accession 0001062993-16-011353
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Wegman
Officer — President · Director · 10% Owner
Period of report
Aug 30, 2016
Accepted (ET)
Aug 30, 2016 · 7:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.001 par value | Aug 30, 2016 | M | 25,000 | $0.83 | A | 212,549 | D | |
| Common Stock, $.001 par value | Aug 30, 2016 | M | 100,000 | $0.83 | A | 312,549 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.83 | Aug 30, 2016 | M | 25,000 | D | Sep 6, 2006 | Sep 5, 2016 | Common Stock, $.001 par value | 25,000 | 0 | D |
| Stock Option (Right to Buy)F1 | $0.83 | Aug 30, 2016 | M | 100,000 | D | — | Sep 5, 2016 | Common Stock, $.001 par value | 100,000 | 0 | D |
Explanation of responses
- F1On September 6, 2006, the reporting person was granted an option to purchase 100,000 shares of the Issuer's Common Stock. The option vested in two equal installments based on the reporting person's satisfaction of two distinct performance conditions. The first performance related condition was satisfied on October 24, 2007, resulting in the vesting of the option as to 50,000 shares. The second performance related condition was satisfied on April 2, 2010, resulting in the vesting of the option as to the remaining 50,000 shares.